Apellis Pharmaceuticals has a total of 371 patents globally, out of which 144 have been granted. Of these 371 patents, more than 71% patents are active. The United States of America is where Apellis Pharmaceuticals has filed the maximum number of patents, followed by Hong Kong (S.A.R.) and Europe (EPO). Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Apellis Pharmaceuticals.
Apellis Pharmaceuticals was founded in 2008. Apellis Pharmaceuticals specializes in creating innovative therapeutics and drug delivery solutions aimed at treating chronic inflammatory diseases, with a focus on addressing unmet medical needs in this therapeutic area.
Do read about some of the most popular patents of Apellis Pharmaceuticals which have been covered by us in this article and also you can find Apellis Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Apellis Pharmaceuticals patent portfolio.
How many patents does Apellis Pharmaceuticals have?
Apellis Pharmaceuticals has a total of 371 patents globally. These patents belong to 50 unique patent families. Out of 371 patents, 266 patents are active.
How Many Patents did Apellis Pharmaceuticals File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Apellis Pharmaceuticals Applications Filed | Apellis Pharmaceuticals Patents Granted |
| 2024 | 10 | 11 |
| 2023 | 16 | 12 |
| 2022 | 46 | 24 |
| 2021 | 39 | 25 |
| 2020 | 23 | 14 |
| 2019 | 21 | 14 |
| 2018 | 32 | 11 |
| 2017 | 21 | 14 |
| 2016 | 22 | 4 |
| 2015 | 8 | 8 |
How many Apellis Pharmaceuticals patents are Alive/Dead?
Worldwide Patents
How Many Patents did Apellis Pharmaceuticals File in Different Countries?
Countries in which Apellis Pharmaceuticals Filed Patents
| Country | Patents |
| United States of America | 70 |
| Hong Kong (S.A.R.) | 30 |
| Europe (EPO) | 29 |
| Japan | 28 |
| Australia | 26 |
| China | 17 |
| Israel | 14 |
| Canada | 13 |
| Mexico | 13 |
| India | 10 |
| Brazil | 9 |
| Korea (South) | 7 |
| Denmark | 7 |
| Austria | 7 |
| Germany | 6 |
| Spain | 6 |
| Macao | 6 |
| Russia | 5 |
| Poland | 5 |
| Norway | 4 |
| Hungary | 3 |
| Taiwan | 2 |
| Lithuania | 2 |
| Cyprus | 2 |
| Portugal | 2 |
| Netherlands | 1 |
| Finland | 1 |
| Tunisia | 1 |
| Singapore | 1 |
| Slovenia | 1 |
| Italy | 1 |
| Croatia | 1 |
| Serbia | 1 |
| Albania | 1 |
| Former Yugoslav Republic of Macedonia | 1 |
| Malta | 1 |
| Slovakia | 1 |
Where are Research Centers of Apellis Pharmaceuticals Patents Located?
10 Best Apellis Pharmaceuticals Patents
US20060257359A1 is the most popular patent in the Apellis Pharmaceuticals portfolio. It has received 91 citations so far from companies like Searete Llc, Potentia Pharmaceuticals, Morphotek.
Below is the list of 10 most cited patents of Apellis Pharmaceuticals:
| Publication Number | Citation Count |
| US20060257359A1 | 91 |
| US20160015810A1 | 50 |
| WO2012178083A1 | 46 |
| US20160067357A1 | 45 |
| US8580735B2 | 45 |
| WO2012155107A1 | 43 |
| US8168584B2 | 41 |
| US9421240B2 | 37 |
| US20160060297A1 | 37 |
| US20110190221A1 | 37 |
What are Apellis Pharmaceuticals key innovation segments?
What Technologies are Covered by Apellis Pharmaceuticals?
The chart below distributes patents filed by Apellis Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Apellis Pharmaceuticals thinks it’s important to protect particular technology inventions.
R&D Focus: How has Apellis Pharmaceuticals search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Apellis Pharmaceuticals?